June 29, 2020 / 9:24 PM / 16 days ago

BRIEF-Luminex Submits Emergency Use Authorization Request To U.S. FDA For Covid-19 Antibody Test

June 29 (Reuters) - Luminex Corp:

* LUMINEX SUBMITS EMERGENCY USE AUTHORIZATION REQUEST TO U.S. FDA FOR COVID-19 ANTIBODY TEST

* LUMINEX CORP - PLANS TO LAUNCH RESEARCH USE ONLY (RUO) VERSION OF ASSAY LATER THIS MONTH

* LUMINEX - ASSAY USES MULTIPLEXING FOR HIGHLY SPECIFIC AND SENSITIVE DETECTION OF IGG ANTIBODIES AGAINST SARS-COV-2

* LUMINEX - ASSAY RUNS ON ALL XMAP® PLATFORMS, GOLD STANDARD FOR MULTIPLEX SEROLOGICAL TESTING, AND DETECTS PREVIOUS INFECTION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below